
Sign up to save your podcasts
Or
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:
4.3
106106 ratings
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leora R. Feldstein, PhD, US Centers for Disease Control and Prevention, about the effectiveness of bivalent COVID-19 vaccines in children and adolescents. Related Content:
493 Listeners
38 Listeners
9 Listeners
18 Listeners
19 Listeners
14 Listeners
11 Listeners
5 Listeners
7 Listeners
9 Listeners
21 Listeners
87 Listeners
5 Listeners
29 Listeners
14 Listeners
5 Listeners
20 Listeners
2 Listeners
163 Listeners